| Organoid modeling of the tumor immune microenvironment JT Neal, X Li, J Zhu, V Giangarra, CL Grzeskowiak, J Ju, IH Liu, SH Chiou, ... Cell 175 (7), 1972-1988. e16, 2018 | 1044 | 2018 |
| Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer AJ Pantuck, JT Leppert, N Zomorodian, W Aronson, J Hong, RJ Barnard, ... Clinical Cancer Research 12 (13), 4018-4026, 2006 | 664 | 2006 |
| Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. JS Lam, O Shvarts, JT Leppert, RA Figlin, AS Belldegrun The Journal of urology 173 (6), 1853, 2005 | 525 | 2005 |
| Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy AJ Pantuck, DB Seligson, T Klatte, H Yu, JT Leppert, L Moore, T O'Toole, ... Cancer 109 (11), 2257-2267, 2007 | 434 | 2007 |
| Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification … JS Lam, O Shvarts, JT Leppert, AJ Pantuck, RA Figlin, AS Belldegrun The Journal of urology 174 (2), 466, 2005 | 396 | 2005 |
| Flexible ureteroscopy and laser lithotripsy for single intrarenal stones 2 cm or greater—is this the new frontier? A Breda, O Ogunyemi, JT Leppert, JS Lam, PG Schulam The Journal of urology 179 (3), 981-984, 2008 | 367 | 2008 |
| Flexible ureteroscopy and laser lithotripsy for multiple unilateral intrarenal stones A Breda, O Ogunyemi, JT Leppert, PG Schulam European urology 55 (5), 1190-1197, 2009 | 347 | 2009 |
| Hypoxia-inducible factor 1α in clear cell renal cell carcinoma T Klatte, DB Seligson, SB Riggs, JT Leppert, MK Berkman, MD Kleid, ... Clinical cancer research 13 (24), 7388-7393, 2007 | 270 | 2007 |
| Novel approaches in the therapy of metastatic renal cell carcinoma JS Lam, JT Leppert, AS Belldegrun, RA Figlin World journal of urology 23, 202-212, 2005 | 254 | 2005 |
| Prostate magnetic resonance imaging interpretation varies substantially across radiologists GA Sonn, RE Fan, P Ghanouni, NN Wang, JD Brooks, AM Loening, ... European urology focus 5 (4), 592-599, 2019 | 237 | 2019 |
| Secondary hormonal therapy for advanced prostate cancer JS Lam, JT Leppert, SN Vemulapalli, O Shvarts, AS Belldegrun The Journal of urology 175 (1), 27-34, 2006 | 223 | 2006 |
| Diabetic severity and risk of kidney stone disease AE Weinberg, CJ Patel, GM Chertow, JT Leppert European urology 65 (1), 242-247, 2014 | 152 | 2014 |
| Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era SL Conti, IC Thomas, JC Hagedorn, BI Chung, GM Chertow, TH Wagner, ... International journal of cancer 134 (9), 2245-2252, 2014 | 147 | 2014 |
| Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. JS Lam, JT Leppert, RA Figlin, AS Belldegrun Urology 66 (5 Suppl), 1, 2005 | 141 | 2005 |
| Surveillance following radical or partial nephrectomy for renal cell carcinoma JS Lam, JT Leppert, RA Figlin, AS Belldegrun Current urology reports 6 (1), 7-18, 2005 | 140 | 2005 |
| Central neuronal loss and behavioral impairment in mice lacking neurotrophin receptor p75 DA Peterson, HA Dickinson‐Anson, JT Leppert, KF Lee, FH Gage Journal of Comparative Neurology 404 (1), 1-20, 1999 | 133 | 1999 |
| Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey CJ Patel, DH Rehkopf, JT Leppert, WM Bortz, MR Cullen, GM Chertow, ... International journal of epidemiology 42 (6), 1795-1810, 2013 | 128 | 2013 |
| Prevention of bladder cancer: a review JT Leppert, O Shvarts, K Kawaoka, R Lieberman, AS Belldegrun, ... European urology 49 (2), 226-234, 2006 | 118 | 2006 |
| Screening rates for primary aldosteronism in resistant hypertension: a cohort study G Jaffe, Z Gray, G Krishnan, M Stedman, Y Zheng, J Han, GM Chertow, ... Hypertension 75 (3), 650-659, 2020 | 113 | 2020 |
| The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis JL Sylman, A Mitrugno, M Atallah, GW Tormoen, JJ Shatzel, ... Frontiers in oncology 8, 78, 2018 | 109 | 2018 |
James D. BrooksKeith & Jan Hurlbut Professor, Stanford UniversityVerified email at stanford.edu
